BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23969726)

  • 21. MAPKAP kinase 2 overexpression influences prognosis in gastrointestinal stromal tumors and associates with copy number variations on chromosome 1 and expression of p38 MAP kinase and ETV1.
    Birner P; Beer A; Vinatzer U; Stary S; Höftberger R; Nirtl N; Wrba F; Streubel B; Schoppmann SF
    Clin Cancer Res; 2012 Apr; 18(7):1879-87. PubMed ID: 22351694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-152 inhibits tumor cell growth while inducing apoptosis via the transcriptional repression of cathepsin L in gastrointestinal stromal tumor.
    Lu HJ; Yan J; Jin PY; Zheng GH; Qin SM; Wu DM; Lu J; Zheng YL
    Cancer Biomark; 2018 Feb; 21(3):711-722. PubMed ID: 29278883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 modulation as a therapeutic strategy in gastrointestinal stromal tumors.
    Henze J; Mühlenberg T; Simon S; Grabellus F; Rubin B; Taeger G; Schuler M; Treckmann J; Debiec-Rychter M; Taguchi T; Fletcher JA; Bauer S
    PLoS One; 2012; 7(5):e37776. PubMed ID: 22662219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KIT Exon 11 Codons 557-558 Deletion Mutation Promotes Liver Metastasis Through the CXCL12/CXCR4 Axis in Gastrointestinal Stromal Tumors.
    Wang HC; Li TY; Chao YJ; Hou YC; Hsueh YS; Hsu KH; Shan YS
    Clin Cancer Res; 2016 Jul; 22(14):3477-87. PubMed ID: 26936919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-125a-5p regulation increases phosphorylation of FAK that contributes to imatinib resistance in gastrointestinal stromal tumors.
    Huang WK; Akçakaya P; Gangaev A; Lee L; Zeljic K; Hajeri P; Berglund E; Ghaderi M; Åhlén J; Bränström R; Larsson C; Lui WO
    Exp Cell Res; 2018 Oct; 371(1):287-296. PubMed ID: 30149002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.
    Koelz M; Lense J; Wrba F; Scheffler M; Dienes HP; Odenthal M
    Int J Oncol; 2011 Feb; 38(2):503-11. PubMed ID: 21132270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-4510 acts as a tumor suppressor in gastrointestinal stromal tumor by targeting APOC2.
    Chen Y; Qin C; Cui X; Geng W; Xian G; Wang Z
    J Cell Physiol; 2020 Jul; 235(7-8):5711-5721. PubMed ID: 31975384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors.
    Pantaleo MA; Ravegnini G; Astolfi A; Simeon V; Nannini M; Saponara M; Urbini M; Gatto L; Indio V; Sammarini G; Santini D; Ferracin M; Negrini M; Hrelia P; Biasco G; Angelini S
    Epigenomics; 2016 Oct; 8(10):1347-1366. PubMed ID: 27625077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An inhibitor of the acetyltransferases CBP/p300 exerts antineoplastic effects on gastrointestinal stromal tumor cells.
    Gu ML; Wang YM; Zhou XX; Yao HP; Zheng S; Xiang Z; Ji F
    Oncol Rep; 2016 Nov; 36(5):2763-2770. PubMed ID: 27633918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor.
    Yamamoto H; Kohashi K; Tsuneyoshi M; Oda Y
    Pathobiology; 2011; 78(3):132-9. PubMed ID: 21613800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and Are Targetable by BET Bromodomain Inhibition.
    Hemming ML; Lawlor MA; Andersen JL; Hagan T; Chipashvili O; Scott TG; Raut CP; Sicinska E; Armstrong SA; Demetri GD; Bradner JE
    Cancer Res; 2019 Mar; 79(5):994-1009. PubMed ID: 30630822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The V654A second-site KIT mutation increases tumor oncogenesis and STAT activation in a mouse model of gastrointestinal stromal tumor.
    Zhang JQ; Bosbach B; Loo JK; Vitiello GA; Zeng S; Seifert AM; Medina BD; Param NJ; Maltbaek JH; Rossi F; Antonescu CR; Besmer P; DeMatteo RP
    Oncogene; 2020 Dec; 39(49):7153-7165. PubMed ID: 33024275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of imatinib vary with the types of KIT-mutation in gastrointestinal stromal tumor cell lines.
    Noma K; Naomoto Y; Gunduz M; Matsuoka J; Yamatsuji T; Shirakawa Y; Nobuhisa T; Okawa T; Takaoka M; Tomono Y; Hiroyuki O; Gunduz E; Tanaka N
    Oncol Rep; 2005 Sep; 14(3):645-50. PubMed ID: 16077968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs and Gastrointestinal Stromal Tumor.
    Akçakaya P; Lui WO
    Adv Exp Med Biol; 2015; 889():51-70. PubMed ID: 26658996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. microRNA-218 increase the sensitivity of gastrointestinal stromal tumor to imatinib through PI3K/AKT pathway.
    Fan R; Zhong J; Zheng S; Wang Z; Xu Y; Li S; Zhou J; Yuan F
    Clin Exp Med; 2015 May; 15(2):137-44. PubMed ID: 24706111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KIT over-expression by p55PIK-PI3K leads to Imatinib-resistance in patients with gastrointestinal stromal tumors.
    Lai S; Wang G; Cao X; Luo X; Wang G; Xia X; Hu J; Wang J
    Oncotarget; 2016 Jan; 7(2):1367-79. PubMed ID: 26587973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors.
    Isosaka M; Niinuma T; Nojima M; Kai M; Yamamoto E; Maruyama R; Nobuoka T; Nishida T; Kanda T; Taguchi T; Hasegawa T; Tokino T; Hirata K; Suzuki H; Shinomura Y
    PLoS One; 2015; 10(7):e0133754. PubMed ID: 26214687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-128 acts as a suppressor in the progression of gastrointestinal stromal tumor by targeting B-lymphoma Mo-MLV insertion region 1.
    Wu J; Wang C; Cui X; Liu L; Wang L; Wang J; Xue X; Dang T
    Clin Transl Oncol; 2024 Feb; 26(2):363-374. PubMed ID: 38103120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The heat shock protein 90 inhibitor IPI-504 induces KIT degradation, tumor shrinkage, and cell proliferation arrest in xenograft models of gastrointestinal stromal tumors.
    Floris G; Debiec-Rychter M; Wozniak A; Stefan C; Normant E; Faa G; Machiels K; Vanleeuw U; Sciot R; Schöffski P
    Mol Cancer Ther; 2011 Oct; 10(10):1897-908. PubMed ID: 21825009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-30a targets BECLIN-1 to inactivate autophagy and sensitizes gastrointestinal stromal tumor cells to imatinib.
    Chen W; Li Z; Liu H; Jiang S; Wang G; Sun L; Li J; Wang X; Yu S; Huang J; Dong Y
    Cell Death Dis; 2020 Mar; 11(3):198. PubMed ID: 32251287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.